Literature DB >> 6263651

Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals.

N G Bowery, A Doble, D R Hill, A L Hudson, J S Shaw, M J Turnbull, R Warrington.   

Abstract

The action of gamma-aminobutyric acid (GABA) and related compounds on rat isolated atria and mouse and guinea pig isolated vas deferens has been studied. GABA depressed the evoked but not basal release of [3H]noradrenaline from atria (IC50 4 micro M) and reduced the twitch responses of the vas deferens (IC50 3 micro M) in a dose-dependent manner. These depressant effects were not prevented by recognized GABA antagonists such as bicuculline and picrotoxin. Numerous GABA analogues, in particular 3-aminopropanesulphonic acid, failed to mimic the action of GABA. However, beta-p-chlorophenyl GABA (baclofen) was stereospecifically active. Other related beta-substituted derivatives were also active but to a lesser degree than GABA. Pretreatment of the vas deferens with the neuronal GABA uptake inhibitors 2,4-diaminobutyric acid or cis-3-aminocyclohexanecarboxylic acid potentiated the action of GABA. These data suggest the presence of a bicuculline-insensitive GABA receptor on autonomic nerve terminals. Preliminary observations indicate a lack of chloride ion dependence in the action of GABA at this site.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263651     DOI: 10.1016/0014-2999(81)90386-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  73 in total

1.  The effects of baclofen on calcium channel currents in dorsal sensory cells of the spinal cord in the lamprey.

Authors:  I V Batueva; J T Buchanan; E A Tsvetkov; A K Sagatelyan; N P Veselkin
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

Review 2.  GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids.

Authors:  Valerio Magnaghi; Marinella Ballabio; Antonio Consoli; Jeremy J Lambert; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  CSF baclofen levels after intrathecal administration in severe spasticity.

Authors:  B Sallerin-Caute; Y Lazorthes; B Monsarrat; J Cros; R Bastide
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  The effects of baclofen on spinal and supraspinal micturition reflexes in rats.

Authors:  C A Maggi; P Santicioli; S Giuliani; M Furio; B Conte; P Meli; L Gragnani; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

5.  Pharmacological and biochemical characteristics of partially purified GABAB receptor.

Authors:  Y Ohmori; K Kuriyama
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

6.  Chronic lesion of corticostriatal fibers reduces GABAB but not GABAA binding in rat caudate putamen: an autoradiographic study.

Authors:  R Moratalla; N G Bowery
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

7.  3-Aminopropylphosphinic acid--a potent, selective GABAB receptor agonist in the guinea-pig ileum and rat anococcygeus muscle.

Authors:  J M Hills; R A Dingsdale; M E Parsons; R E Dolle; W Howson
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

8.  An in vitro study of the relationship between GABA receptor function and propulsive motility in the distal colon of the rabbit.

Authors:  M Tonini; A Crema; G M Frigo; C A Rizzi; L Manzo; S M Candura; L Onori
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

9.  The motor response to ethylenediamine of the rat isolated duodenum: involvement of GABAergic transmission?

Authors:  C A Maggi; S Giuliani; P Santicioli; S Selleri; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

10.  Dual population of GABAA and GABAB receptors in rat pars intermedia demonstrated by release of alpha MSH caused by barium ions.

Authors:  B A Demeneix; E Desaulles; P Feltz; J P Loeffler
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.